First report of colistin resistance among carbapenem-resistant Acinetobacter baumannii isolates recovered from hospitalized patients in Egypt
- PMID: 30224972
- PMCID: PMC6138847
- DOI: 10.1016/j.nmni.2018.08.007
First report of colistin resistance among carbapenem-resistant Acinetobacter baumannii isolates recovered from hospitalized patients in Egypt
Abstract
Acinetobacter baumannii is an opportunistic pathogen that poses an increasing threat in the health-care community. Colistin is one of the promising options for treatment of multidrug-resistant A. baumannii. The current study investigated the emergence of colistin resistance among carbapenem-resistant strains of A. baumannii in Egypt. It involved identification of clinically recovered A. baumannii isolates using the VITEK-2 system, and screening of their antimicrobial susceptibilities using broth microdilution techniques. Characterizations of carbapenemase and 16S rRNA methyltransferase genes were performed using PCR. Colistin-resistance determinants were characterized by sequencing. Carbapenem-resistant A. baumannii isolates (n = 40) showed resistance to amoxicillin-clavulanic acid, cefotaxime, gentamicin and amikacin. Most isolates revealed resistance to ciprofloxacin (95%; n = 38) and co-trimoxazole (92.5%; n = 37). Resistance to tobramycin and doxycycline was 80% (n = 32) and 62.5% (n = 25), respectively. Only two A. baumannii isolates demonstrated colistin resistance. Carbapenemase activity was tested by modified Hodge test and 78% of isolates were positive. All isolates carried blaOXA-51-like genes whereas bla-OXA-23 was detected in 80% (n = 32) of isolates. Among 16S rRNA methylase genes, armA was detected in 22.5% (n = 9) of the isolates. Analyses of lpxA, lpxC, lpxD and pmrCAB genetic sequences suggest that colistin resistance could be attributed to mutations in pmrCAB genes. Alarmingly, colistin resistance was associated with high levels of resistance to other antimicrobials. The current findings represent a serious health-care problem capable of restraining future therapeutic options.
Keywords: Acinetobacter baumannii; armA; blaOXA-23; colistin resistance; pmrABCgenes.
Figures

Similar articles
-
Molecular Characterization of Carbapenem/Colistin-Resistant Acinetobacter baumannii Clinical Isolates from Egypt by Whole-Genome Sequencing.Infect Drug Resist. 2020 Dec 16;13:4487-4493. doi: 10.2147/IDR.S288865. eCollection 2020. Infect Drug Resist. 2020. PMID: 33364795 Free PMC article.
-
[Investigation of oxacillinase genes in nosocomial multidrug-resistant Acinetobacter baumannii isolates by multiplex PCR and evaluation of their clonal relationship with Rep-PCR].Mikrobiyol Bul. 2015 Apr;49(2):249-58. doi: 10.5578/mb.8884. Mikrobiyol Bul. 2015. PMID: 26167825 Turkish.
-
Characterization of Acinetobacter baumannii clinical isolates carrying bla(OXA-23) carbapenemase and 16S rRNA methylase armA genes in Yemen.Microb Drug Resist. 2014 Dec;20(6):604-9. doi: 10.1089/mdr.2014.0018. Microb Drug Resist. 2014. PMID: 24901296
-
Interplay between Colistin Resistance, Virulence and Fitness in Acinetobacter baumannii.Antibiotics (Basel). 2017 Nov 21;6(4):28. doi: 10.3390/antibiotics6040028. Antibiotics (Basel). 2017. PMID: 29160808 Free PMC article. Review.
-
Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology.Antibiotics (Basel). 2023 Mar 4;12(3):516. doi: 10.3390/antibiotics12030516. Antibiotics (Basel). 2023. PMID: 36978383 Free PMC article. Review.
Cited by
-
Polymyxin E-Resistant Gram-Negative Bacteria in Tunisia and Neighboring Countries: Are There Commonalities?Infect Drug Resist. 2021 Nov 16;14:4821-4832. doi: 10.2147/IDR.S327718. eCollection 2021. Infect Drug Resist. 2021. PMID: 34815678 Free PMC article. Review.
-
Understanding the Epidemiology of Multi-Drug Resistant Gram-Negative Bacilli in the Middle East Using a One Health Approach.Front Microbiol. 2019 Aug 23;10:1941. doi: 10.3389/fmicb.2019.01941. eCollection 2019. Front Microbiol. 2019. PMID: 31507558 Free PMC article. Review.
-
Acinetobacter baumannii Global Clone-Specific Resistomes Explored in Clinical Isolates Recovered from Egypt.Antibiotics (Basel). 2023 Jul 4;12(7):1149. doi: 10.3390/antibiotics12071149. Antibiotics (Basel). 2023. PMID: 37508245 Free PMC article.
-
Colistin and Carbapenem-Resistant Acinetobacter baumannii Aci46 in Thailand: Genome Analysis and Antibiotic Resistance Profiling.Antibiotics (Basel). 2021 Aug 30;10(9):1054. doi: 10.3390/antibiotics10091054. Antibiotics (Basel). 2021. PMID: 34572636 Free PMC article.
-
Syzygium aromaticum Extracts as a Potential Antibacterial Inhibitors against Clinical Isolates of Acinetobacter baumannii: An In-Silico-Supported In-Vitro Study.Antibiotics (Basel). 2021 Sep 1;10(9):1062. doi: 10.3390/antibiotics10091062. Antibiotics (Basel). 2021. PMID: 34572644 Free PMC article.
References
-
- Arroyo L.A., Herrera C.M., Fernandez L., Hankins J.V., Trent M.S., Hancock R.E. The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A. Antimicrob Agents Chemother. 2011;55:3743–3751. - PMC - PubMed
-
- Bassetti M., Righi E., Esposito S., Petrosillo N., Nicolini L. Drug treatment for multidrug-resistant Acinetobacter baumannii infections. Future Microbiol. 2008;3:649–660. - PubMed
-
- Bonomo R.A., Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis. 2006;43(Suppl. 2):S49–S56. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases